drug

QUESTIONNAIRES

Questionnaires
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Centre Hospitalier Charles Perrens, Bordeaux
4 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

4
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
NCT06610500—Completed
Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs
NCT04590300—Completed
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia
NCT03699501—Completed
Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration
NCT02484521—Completed

KOLs & investigators

3
Clelia QUILES, MD
elad kurante, MD
Anne-Cécile GALLO BLANDIN, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Centre Hospitalier Charles Perrens, Bordeaux
company
trial
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
trial
Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs
NA
trial
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia
trial
Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration
NA
trial
indication
Schizophrenia
indication
Medication Adherence
indication
Medication Adherence
indication
Agranulocytosis
indication
KOL
Clelia QUILES, MD
KOL score —
person
elad kurante, MD
KOL score —
person
Anne-Cécile GALLO BLANDIN, MD
KOL score —
person